Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2026 · 10-Q
Revenue$44.36M$44.36M−23.6% vs Q2 2025 Net Income-$8.52M-$8.52MN/M vs Q2 2025 EPS Diluted-$0.41-$0.41N/M vs Q2 2025 Gross Profit$12,415,000−33.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,174,000N/M Free Cash Flowderived-$4,798,000N/M Margins · derivedGross margin28.0%−4.4 pt vs Q2 2025
Operating margin-18.9%−19.8 pt vs Q2 2025
Net margin-19.2%−23.2 pt vs Q2 2025
ended Sep 30, 2025 · filed Dec 19, 2025 · 80 d after period end